BR0116698A - Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos - Google Patents
Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmosInfo
- Publication number
- BR0116698A BR0116698A BR0116698-0A BR0116698A BR0116698A BR 0116698 A BR0116698 A BR 0116698A BR 0116698 A BR0116698 A BR 0116698A BR 0116698 A BR0116698 A BR 0116698A
- Authority
- BR
- Brazil
- Prior art keywords
- obtaining
- cyclodextrin
- mixtures
- modafinil compound
- compound
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 4
- -1 Modafinil compound Chemical class 0.000 title abstract 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001165 modafinil Drugs 0.000 title abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
"COMPOSTO DE MODAFINILA E MISTURAS DE CICLODEXTRINA, USO E MéTODO DE OBTENçãO DOS MESMOS". Misturas de um composto de modafinila com ciclodextrina, métodos para uso desta mistura, e composições destas misturas são descritas acompanhadas dos complexos compreendendo o composto de modafinila e a ciclodextrina, os quais são um teste mascarado e são apropriados para consumo oral em uma solução aquosa.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25668100P | 2000-12-19 | 2000-12-19 | |
US10/023,441 US7141555B2 (en) | 2000-12-19 | 2001-12-18 | Modafinil compound and cyclodextrin mixtures |
PCT/US2001/049189 WO2002056915A2 (en) | 2000-12-19 | 2001-12-19 | Complex of modafinil and cyclodextrin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0116698A true BR0116698A (pt) | 2003-10-21 |
Family
ID=26697157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0116698-0A BR0116698A (pt) | 2000-12-19 | 2001-12-19 | Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos |
Country Status (23)
Country | Link |
---|---|
US (1) | US7141555B2 (pt) |
EP (1) | EP1368063B1 (pt) |
JP (1) | JP4094428B2 (pt) |
KR (1) | KR20040012696A (pt) |
CN (1) | CN100384477C (pt) |
AT (1) | ATE396745T1 (pt) |
AU (1) | AU2002246711B2 (pt) |
BG (1) | BG108009A (pt) |
BR (1) | BR0116698A (pt) |
CA (1) | CA2432126C (pt) |
CZ (1) | CZ20031878A3 (pt) |
DE (1) | DE60134274D1 (pt) |
EA (1) | EA200300705A1 (pt) |
ES (1) | ES2305128T3 (pt) |
HK (1) | HK1059055A1 (pt) |
HU (1) | HUP0401592A2 (pt) |
IL (1) | IL156470A0 (pt) |
MX (1) | MXPA03005505A (pt) |
NO (1) | NO20032788L (pt) |
NZ (1) | NZ526780A (pt) |
PL (1) | PL362474A1 (pt) |
SK (1) | SK9012003A3 (pt) |
WO (1) | WO2002056915A2 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030224006A1 (en) | 2002-03-01 | 2003-12-04 | Zaworotko Michael J. | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
JP2004250390A (ja) * | 2003-02-21 | 2004-09-09 | Taisho Pharmaceut Co Ltd | 鉄化合物配合内服液剤 |
ES2584183T3 (es) | 2003-03-28 | 2016-09-26 | Ares Trading S.A. | Formulaciones de cladribina para suministro mejorado oral y transmucosa |
PT1608344E (pt) * | 2003-03-28 | 2010-09-02 | Ares Trading Sa | Formulações orais de cladribina |
US7566805B2 (en) | 2003-09-04 | 2009-07-28 | Cephalon, Inc. | Modafinil compositions |
MXPA06002507A (es) * | 2003-09-04 | 2006-06-20 | Cephalon Inc | Composiciones de modafinil. |
BRPI0413777A (pt) * | 2003-09-04 | 2006-11-07 | Cephalon Inc | composições de modafinil |
US8153159B2 (en) | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
US20090018202A1 (en) | 2004-02-06 | 2009-01-15 | Cephalon, Inc. | Modafinil compositions |
BRPI0509592A (pt) * | 2004-05-06 | 2007-09-25 | Cydex Inc | formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila |
US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
CN100503647C (zh) * | 2005-11-02 | 2009-06-24 | 南京师范大学 | 羟丙基-磺丁基-β-环糊精及其制备方法、分析方法以及在药学上的应用 |
JP2009543803A (ja) * | 2006-07-12 | 2009-12-10 | エラン・ファルマ・インターナショナル・リミテッド | モダフィニルのナノ粒子製剤 |
JP2009091309A (ja) * | 2007-10-10 | 2009-04-30 | Japan Organo Co Ltd | バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品 |
US10463677B2 (en) | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
KR101026864B1 (ko) * | 2009-10-08 | 2011-04-12 | (주)송호바이오메드 | 고 수용성 2―하이드록시프로필―베타사이클로덱스트린을 유효성분으로 함유하는 비만 질환 예방 및 치료용 조성물 |
WO2011043630A2 (ko) * | 2009-10-08 | 2011-04-14 | (주)송호바이오메드 | 고 수용성 2-하이드록시프로필-베타사이클로덱스트린을 유효성분으로 함유하는 비만 질환 예방 및 치료용 조성물 |
SG10201507554RA (en) | 2010-09-13 | 2015-10-29 | Bev Rx Inc | Aqueous drug delivery system comprising off - flavor masking agent |
US9364549B2 (en) | 2011-11-30 | 2016-06-14 | Andreas Voigt | Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
US9474715B2 (en) | 2011-11-30 | 2016-10-25 | Andreas Voigt | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
KR101719987B1 (ko) | 2015-08-03 | 2017-03-27 | (주)상전정공 | 화물차량의 잠금장치 |
US9855228B1 (en) | 2016-12-14 | 2018-01-02 | Taho Pharmaceuticals Ltd. | Oral solution comprising atomoxetine hydrochloride and methods thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835968B2 (ja) * | 1974-02-25 | 1983-08-05 | 帝人株式会社 | サイクロデキストリン包接化合物の製造法 |
GB1584462A (en) | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
JPS5920230A (ja) | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
FR2593809B1 (fr) | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
JPS62281855A (ja) * | 1986-05-29 | 1987-12-07 | Daikin Ind Ltd | ビタミン,ビタミン誘導体,またはホルモンを含有する包接化合物 |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
JPH035438A (ja) * | 1989-05-31 | 1991-01-11 | Kaken Pharmaceut Co Ltd | フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤 |
SE8902235D0 (sv) * | 1989-06-20 | 1989-06-20 | Haessle Ab | Novel cyclodextrin inclusion complexes |
FR2663225B1 (fr) | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
US5024997A (en) | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
FR2684875B1 (fr) * | 1991-12-13 | 1995-05-24 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique. |
FR2702968B1 (fr) | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
US5843347A (en) | 1993-03-23 | 1998-12-01 | Laboratoire L. Lafon | Extrusion and freeze-drying method for preparing particles containing an active ingredient |
US5866162A (en) | 1993-08-10 | 1999-02-02 | Smithkline Beecham P.L.C. | Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple |
US5618845A (en) | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
US6077871A (en) | 1997-11-26 | 2000-06-20 | Pfizer Inc. | Droloxifene pharmaceutical compositions |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
US6455588B1 (en) * | 1999-08-20 | 2002-09-24 | Cephalon, Inc. | Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
-
2001
- 2001-12-18 US US10/023,441 patent/US7141555B2/en not_active Expired - Fee Related
- 2001-12-19 CA CA2432126A patent/CA2432126C/en not_active Expired - Fee Related
- 2001-12-19 EP EP01994302A patent/EP1368063B1/en not_active Expired - Lifetime
- 2001-12-19 EA EA200300705A patent/EA200300705A1/ru unknown
- 2001-12-19 MX MXPA03005505A patent/MXPA03005505A/es active IP Right Grant
- 2001-12-19 CN CNB018207669A patent/CN100384477C/zh not_active Expired - Fee Related
- 2001-12-19 AU AU2002246711A patent/AU2002246711B2/en not_active Ceased
- 2001-12-19 JP JP2002557422A patent/JP4094428B2/ja not_active Expired - Fee Related
- 2001-12-19 AT AT01994302T patent/ATE396745T1/de not_active IP Right Cessation
- 2001-12-19 PL PL01362474A patent/PL362474A1/xx unknown
- 2001-12-19 HU HU0401592A patent/HUP0401592A2/hu unknown
- 2001-12-19 ES ES01994302T patent/ES2305128T3/es not_active Expired - Lifetime
- 2001-12-19 NZ NZ526780A patent/NZ526780A/en not_active IP Right Cessation
- 2001-12-19 IL IL15647001A patent/IL156470A0/xx unknown
- 2001-12-19 SK SK901-2003A patent/SK9012003A3/sk unknown
- 2001-12-19 BR BR0116698-0A patent/BR0116698A/pt not_active IP Right Cessation
- 2001-12-19 CZ CZ20031878A patent/CZ20031878A3/cs unknown
- 2001-12-19 WO PCT/US2001/049189 patent/WO2002056915A2/en active Search and Examination
- 2001-12-19 DE DE60134274T patent/DE60134274D1/de not_active Expired - Lifetime
- 2001-12-19 KR KR10-2003-7008220A patent/KR20040012696A/ko not_active Application Discontinuation
-
2003
- 2003-06-18 NO NO20032788A patent/NO20032788L/no not_active Application Discontinuation
- 2003-07-18 BG BG108009A patent/BG108009A/xx unknown
-
2004
- 2004-03-22 HK HK04102091A patent/HK1059055A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2432126A1 (en) | 2002-07-25 |
IL156470A0 (en) | 2004-01-04 |
AU2002246711B2 (en) | 2006-12-14 |
US7141555B2 (en) | 2006-11-28 |
SK9012003A3 (en) | 2003-12-02 |
ATE396745T1 (de) | 2008-06-15 |
WO2002056915A3 (en) | 2003-01-03 |
NZ526780A (en) | 2005-07-29 |
ES2305128T3 (es) | 2008-11-01 |
BG108009A (en) | 2004-09-30 |
DE60134274D1 (en) | 2008-07-10 |
US20020160982A1 (en) | 2002-10-31 |
JP4094428B2 (ja) | 2008-06-04 |
CA2432126C (en) | 2011-03-08 |
NO20032788D0 (no) | 2003-06-18 |
MXPA03005505A (es) | 2003-10-06 |
EP1368063A2 (en) | 2003-12-10 |
KR20040012696A (ko) | 2004-02-11 |
CN100384477C (zh) | 2008-04-30 |
WO2002056915A2 (en) | 2002-07-25 |
EP1368063B1 (en) | 2008-05-28 |
CZ20031878A3 (cs) | 2004-10-13 |
JP2004525104A (ja) | 2004-08-19 |
PL362474A1 (en) | 2004-11-02 |
HK1059055A1 (en) | 2004-06-18 |
HUP0401592A2 (hu) | 2004-11-29 |
EA200300705A1 (ru) | 2003-12-25 |
CN1486196A (zh) | 2004-03-31 |
NO20032788L (no) | 2003-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0116698A (pt) | Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos | |
BRPI0417684A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
BR0309546A (pt) | Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii | |
EA200000789A1 (ru) | N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии | |
BR0300500B1 (pt) | composiÇço poliolefÍnica, processo para estabilizaÇço de uma poliolefina e uso de uma mistura. | |
BRPI0017013B8 (pt) | composição de antibiótico azalídeo e método para sua obtenção | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
BR0304859A (pt) | Composição e método para estilização de cabelo | |
CY1113312T1 (el) | Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων | |
CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
BR0114646A (pt) | anticorpos anti-lt-beta-r humanizados | |
BR0008753B1 (pt) | Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida | |
BRPI0414539A (pt) | composto, composição farmacêutica, e, uso de um composto | |
HN2002000319A (es) | Benzamida, heteroarilamida y amidas inversas | |
EA200200530A1 (ru) | Гетероциклические замещенные пиразолоны | |
DE10190550D2 (de) | Kosmetische Zusammensetzung | |
BR0317715A (pt) | Composições e processos de uso de collajolie | |
HRP20110349T1 (hr) | Nova kombinacijska upotreba spoja sulfonamida u liječenju karcinoma | |
BR9810829B1 (pt) | composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica. | |
CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
BRPI0006823B8 (pt) | composição farmacêutica estabilizada, preparação de injeção, e kit comercial | |
BRPI0609765B8 (pt) | mistura de isoalcano, composição cosmética ou farmacêutica, composição cosmética de cabelo, método para a preparação de uma mistura de isoalcano, e, uso da mesma | |
MXPA05007771A (es) | Procedimientos de tratamiento del dolor articular o para mejorar el sueno usando un agonista/antagonista de estrogeno. | |
EA200300450A1 (ru) | Фармацевтические растворы соединений модафинила |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. |